[1]
“Expert Panel Discussion among Psoriasis and Psychodermatology Specialists: How Best to Manage Depressed Psoriasis Patients with Brodalumab”, J of Skin, vol. 3, no. 6, pp. 368–373, Dec. 2019, doi: 10.25251/skin.3.6.1.